Prot# CLTR0308-204: Phase IIB, Multicenter, Randomized, Open Label Trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injections versus Cytarabine and Daunorubicin in Patients with Untreated AML 60-75 Years of Age

  • Tallman, Martin Stuart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/20/091/19/12

Funding

  • Celator Pharmaceuticals, Inc. (CLTR0308-204)